Key Highlights
•
A new global framework for diagnosing a severe lung condition in pregnant and postpartum women (obstetric ARDS) reveals a maternal mortality rate of nearly 50%. This underscores the critical need for early recognition and aggressive treatment, particularly for severe cases and those with high blood lactate levels.
Source →
•
A review proposes that dysfunction in key brain systems that control wakefulness may disrupt sleep and impair the brain’s nightly cleaning process, potentially driving Alzheimer’s disease progression. This highlights a potential new avenue for treatments aimed at improving sleep to slow neurodegeneration.
Source →
•
A large study of inherited neuropathies shows that a specific genetic variant, previously thought to cause disease only when inherited from both parents, can also cause Charcot-Marie-Tooth disease when inherited from just one parent. This finding expands genetic testing guidelines, ensuring more patients receive an accurate diagnosis.
Source →
•
Researchers identified a novel signaling pathway involving SEMA3C and PLXND1 that drives excessive collagen production in keloid scars through the TGF-β1 pathway. This discovery reveals a potential new target for treating these difficult, overgrown scars that often recur after surgery.
Source →
•
A study found that children with Crohn’s disease who have symptoms outside the gut (like joint pain or skin rashes) at diagnosis are more likely to need advanced biologic therapy sooner, but may have a lower risk of needing intestinal surgery. This helps doctors better predict and personalize treatment plans for pediatric patients.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
